These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10583598)

  • 1. Up-modulation of interferon-gamma mediates the enhancement of spontanous cytotoxicity in prolactin-activated natural killer cells.
    Matera L; Contarini M; Bellone G; Forno B; Biglino A
    Immunology; 1999 Nov; 98(3):386-92. PubMed ID: 10583598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
    Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS
    Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.
    Matera L; Bellone G; Lebren JJ; Kelly PA; Hooghe Peters EL; Di Celle PF; Foa R; Contarini M; Avanzi G; Asnaghi V
    Immunology; 1996 Dec; 89(4):619-26. PubMed ID: 9014831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulation and biological activity of interleukin 12.
    Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS
    Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent and synergistic effect of interleukin-2 and prolactin on development of T- and NK-derived LAK effectors.
    Cesano A; Oberholtzer E; Contarini M; Geuna M; Bellone G; Matera L
    Immunopharmacology; 1994; 28(1):67-75. PubMed ID: 7928303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of prolactin receptor and response to prolactin stimulation of human NK cell lines.
    Sun R; Li AL; Wei HM; Tian ZG
    Cell Res; 2004 Feb; 14(1):67-73. PubMed ID: 15040892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant gamma interferon provokes resistance of human breast cancer cells to spontaneous and IL-2 activated non-MHC restricted cytotoxicity.
    Jabrane-Ferrat N; Calvo F; Faille A; Lagabrielle JF; Boisson N; Quillet A; Fradelizi D
    Br J Cancer; 1990 Apr; 61(4):558-62. PubMed ID: 2109997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma.
    Ellis TM; McKenzie RS; Simms PE; Helfrich BA; Fisher RI
    J Immunol; 1989 Dec; 143(12):4282-6. PubMed ID: 2512355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of prolactin in the modulation of NK and LAK cell activity after short- or long-term morphine administration in neoplastic patients.
    Provinciali M; Di Stefano G; Stronati S; Raffaeli W; Pari G; Fabris N
    Int J Immunopharmacol; 1996 Oct; 18(10):577-86. PubMed ID: 9080251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of natural killer cytotoxicity by Escherichia coli-derived human interferon gamma.
    Platsoucas CD
    Scand J Immunol; 1986 Jul; 24(1):93-108. PubMed ID: 3088722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Viscum album oligosaccharide activating human natural cytotoxicity is an interferon gamma inducer.
    Mueller EA; Anderer FA
    Cancer Immunol Immunother; 1990; 32(4):221-7. PubMed ID: 2124513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-candidial activity of natural killer (NK) and lymphokine activated killer (LAK) lymphocytes in vitro.
    Gülay Z; Imir T
    Immunobiology; 1996 Jul; 195(2):220-30. PubMed ID: 8877398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of pituitary hormone prolactin with interleukin-2 and interleukin-12 on production of interferon-gamma by natural killer and T cells.
    Matera L; Mori M
    Ann N Y Acad Sci; 2000; 917():505-13. PubMed ID: 11268378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin response of NK cells, but not of LAK cells, is deficient in patients with carcinoma of oral cavity and during aging.
    Chakraborty A; Chakraborty NG; Chattopadhyay U
    Int J Cancer; 1996 Mar; 66(1):65-9. PubMed ID: 8608969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of NK-like activity in T cells by IL-2/anti-CD3 is linked to expression of a new antitumour receptor with specificity for acetylated mannose.
    Zollner TM; Zhu HG; Anderer FA
    Anticancer Res; 1993; 13(4):923-30. PubMed ID: 8352560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin increases the susceptibility of primary leukemia cells to NK and LAK effectors.
    Oberholtzer E; Contarini M; Veglia F; Cossarizza A; Franceschi C; Geuna M; Provinciali M; Di Stefano G; Sissom J; Brizzi MF; Pegoraro L; Matera L
    Adv Neuroimmunol; 1996; 6(3):233-47. PubMed ID: 8968423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoregulatory properties of ISG15, an interferon-induced cytokine.
    D'Cunha J; Knight E; Haas AL; Truitt RL; Borden EC
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):211-5. PubMed ID: 8552607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.